Srikanth, K., & Sridhanya, V. Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationSrikanth, Krishnagopal, and V. Sridhanya. Comment on Efficacy, Safety, and Tolerability of Lifitegrast 5% Eye Drops: A Randomized, Double-blind, Active-controlled Trial in Indian Patients with Dry Eye Disease. Wolters Kluwer Medknow Publications.
MLA (9th ed.) CitationSrikanth, Krishnagopal, and V. Sridhanya. Comment on Efficacy, Safety, and Tolerability of Lifitegrast 5% Eye Drops: A Randomized, Double-blind, Active-controlled Trial in Indian Patients with Dry Eye Disease. Wolters Kluwer Medknow Publications.